295 related articles for article (PubMed ID: 30825003)
1. Intraductal carcinoma of the prostate: a critical re-appraisal.
Varma M; Delahunt B; Egevad L; Samaratunga H; Kristiansen G
Virchows Arch; 2019 May; 474(5):525-534. PubMed ID: 30825003
[TBL] [Abstract][Full Text] [Related]
2. Intraductal Carcinoma of the Prostate: A Guide for the Practicing Pathologist.
Varma M
Adv Anat Pathol; 2021 Jul; 28(4):276-287. PubMed ID: 33990497
[TBL] [Abstract][Full Text] [Related]
3. Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies.
Chen-Maxwell D; Prendeville S
Histopathology; 2020 Sep; 77(3):503-507. PubMed ID: 32358793
[TBL] [Abstract][Full Text] [Related]
4. Isolated Intraductal Carcinoma of the Prostate in Prostatectomy Specimens: Report of 2 Cases and Review of the Literature.
Grypari IM; Logotheti S; Lazaris AC; Kallidonis P; Fokaefs E; Melachrinou M; Zolota V; Tzelepi V
Int J Surg Pathol; 2020 Dec; 28(8):918-924. PubMed ID: 32456482
[TBL] [Abstract][Full Text] [Related]
5. Head to head: should the intraductal component of invasive prostate cancer be graded?
Varma M; Epstein JI
Histopathology; 2021 Jan; 78(2):231-239. PubMed ID: 32692448
[TBL] [Abstract][Full Text] [Related]
6. Intraductal Carcinoma of the Prostate: Extreme Nuclear Size Is Not a Diagnostic Parameter.
Samaratunga H; Delahunt B; Yaxley JW; Johannsen S; Egevad L
Am J Surg Pathol; 2021 Nov; 45(11):1527-1533. PubMed ID: 34265803
[TBL] [Abstract][Full Text] [Related]
7. Comparison of prostatic adenocarcinoma Gleason 5 and intraductal carcinoma of the prostate with tumor necrosis. A morphometric study.
Acosta AM; Vormittag E; Al Rasheed MRH; Sharif A; Mon KS; Kajdacsy-Balla A; Mohapatra G
Pathol Res Pract; 2018 Oct; 214(10):1681-1685. PubMed ID: 30195638
[TBL] [Abstract][Full Text] [Related]
8. Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread.
Sorvina A; Martini C; Prabhakaran S; Logan JM; S-Y Ung B; Moore C; Johnson IRD; Lazniewska J; Tewari P; Malone V; Brooks RD; Hickey SM; Caruso MC; Klebe S; Karageorgos L; O'Leary JJ; Delahunt B; Samaratunga H; Brooks DA
Pathology; 2023 Oct; 55(6):792-799. PubMed ID: 37422404
[TBL] [Abstract][Full Text] [Related]
9. Grade group 4 prostate cancer without intraductal carcinoma on biopsy is more likely to be downgraded on prostatectomy than with intraductal carcinoma.
Trabzonlu L; Chaiprasit T; Kontosis A; Picken M
Virchows Arch; 2024 Mar; 484(3):517-520. PubMed ID: 38267757
[TBL] [Abstract][Full Text] [Related]
10. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.
Robinson BD; Epstein JI
J Urol; 2010 Oct; 184(4):1328-33. PubMed ID: 20723921
[TBL] [Abstract][Full Text] [Related]
11. Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade Carcinoma.
Russell DH; Epstein JI
Am J Surg Pathol; 2022 Feb; 46(2):233-240. PubMed ID: 34619708
[TBL] [Abstract][Full Text] [Related]
12. Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.
Samaratunga H; Delahunt B; Egevad L; Srigley JR; Billis A; Bostwick DG; Camparo P; Cheng L; Clouston D; Denham J; Furusato B; Hartmann A; Jufe L; Kench J; Kenwright DN; Kristiansen G; Leite KRM; MacLennan GT; Merrimen J; Moch H; Oxley J; Pan CC; Paner G; Ro J; Sesterhenn IAM; Shanks J; Thunders M; Tsuzuki T; Wheeler T; Yaxley JW; Varma M
Pathology; 2020 Feb; 52(2):192-196. PubMed ID: 31843189
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance.
Ericson KJ; Wu SS; Lundy SD; Thomas LJ; Klein EA; McKenney JK
J Urol; 2020 Feb; 203(2):311-319. PubMed ID: 31483693
[TBL] [Abstract][Full Text] [Related]
14. Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.
Egevad L; Delahunt B; Kristiansen G; Samaratunga H; Varma M
Pathology; 2018 Jan; 50(1):60-73. PubMed ID: 29199015
[TBL] [Abstract][Full Text] [Related]
15. Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists.
Varma M; Egevad L; Algaba F; Berney D; Bubendorf L; Camparo P; Comperat E; Erbersdobler A; Griffiths D; Grobholz R; Haitel A; Hulsbergen-van de Kaa C; Langner C; Loftus B; Lopez-Beltran A; Mayer N; Nesi G; Oliveira P; Oxley J; Rioux-Leclercq N; Seitz G; Shanks J; Kristiansen G
J Clin Pathol; 2016 Oct; 69(10):852-7. PubMed ID: 26926101
[TBL] [Abstract][Full Text] [Related]
16. Intraductal carcinoma of the prostate: What we know and what we do not know.
Chen X; Ding B; Zhang P; Geng S; Xu J; Han B
Pathol Res Pract; 2018 May; 214(5):612-618. PubMed ID: 29628124
[TBL] [Abstract][Full Text] [Related]
17. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
Cohen RJ; Wheeler TM; Bonkhoff H; Rubin MA
Arch Pathol Lab Med; 2007 Jul; 131(7):1103-9. PubMed ID: 17616999
[TBL] [Abstract][Full Text] [Related]
18. [The Value of MRI Texture Analysis in Identifying Intraductal Carcinoma of the Prostate Gland].
Chu L; Si Y; Liu RB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 51(1):42-48. PubMed ID: 31950788
[TBL] [Abstract][Full Text] [Related]
19. Premalignancy in Prostate Cancer: Rethinking What we Know.
De Marzo AM; Haffner MC; Lotan TL; Yegnasubramanian S; Nelson WG
Cancer Prev Res (Phila); 2016 Aug; 9(8):648-56. PubMed ID: 26813971
[TBL] [Abstract][Full Text] [Related]
20. Grading Intraductal Carcinoma of the Prostate; ISUP versus GUPS Recommendations.
Shahid A; Mushtaq S; Maqbool H; Hassan U; Hussain M; Syed M
J Coll Physicians Surg Pak; 2023 Apr; 33(4):396-399. PubMed ID: 37190710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
